This newsletter deliberately uses three explicit levels of certainty: [DEMONSTRATED FACT] — statements supported by direct, published experimental evidence. [PLAUSIBLE BIOLOGICAL REASONING] — inferences based on known mechanisms, without direct clinical evidence. [RESEARCH HYPOTHESIS] — propositions that emerge from scientific reasoning but lack experimental validation. This distinction reflects a commitment to scientific integrity.
| Telomere Shortening | With each cell division, telomeres progressively shorten. When they reach a critical length, the cell enters senescence or apoptosis. The main molecular marker of the 'cellular biological clock'. (Hayflick, 1965; Blackburn et al., Nobel 2009) |
| Oxidative Stress | Mitochondrial ROS production causes cumulative damage to DNA, proteins, and lipids. In adipose tissue MSCs from older donors, mitochondrial oxidative stress is significantly higher. (Sadie-Van Gijsen, 2021) |
| Replicative Senescence | Cells that reach the Hayflick limit (~50–70 divisions) express SA-β-galactosidase, p16INK4a, and p21. ASCs from older donors express higher levels of these markers. (Fabian et al., J Transl Med, 2014) |
| SASP | Senescent cells secrete pro-inflammatory cytokines (IL-6, TNF-α, MMPs) that propagate aging to neighboring cells. (Cell & Mol Biol Lett, 2022) |
| Epigenetics | The DNA methylation pattern changes over time — Horvath's 'epigenetic clock'. It requires active metabolism to progress. |
All cellular aging processes — telomere shortening, oxidative stress, replicative senescence, SASP, and epigenetic drift — require active metabolism to progress. They are time- and temperature-dependent processes, not instantaneous events.
At -196°C, all metabolic activity ceases. Molecular motion is virtually nonexistent. Biochemical reactions that require activation energy — including all cellular aging processes — are suspended. This state is referred to in the literature as 'suspended animation'. Source: Jang et al., Clin Exp Reprod Med, 2017; PMC5395684.
Telomere shortening occurs exclusively during cell division — a process that requires DNA synthesis and mitosis. At -196°C, cell division does not occur. Therefore, telomere shortening does not occur during cryogenic storage. This is basic biochemistry, not inference. Source: Blackburn EH et al., Nobel Lecture, 2009.
A cell cryopreserved at the time of collection carries, upon thawing, the biological markers corresponding to its state at collection — not at the time of use. Material thawed at T+10 years reflects the biology of T₀, not T₀ + 10 years.
• NOT SUPPORTED: that cryopreserved adipose tissue produces superior clinical outcomes to fresh tissue collected at the same time. Such direct comparative data do not yet exist.
• NOT SUPPORTED: that every biological difference between young and old ASCs translates directly into a clinical difference. The relationship between cellular phenotype → clinical outcome is neither linear nor universal.
• NOT SUPPORTED: an ideal age window for collection based on clinical evidence. Existing studies identify trends — not a precise threshold.